Special Issues in Hypertension

Front Matter....Pages i-x
Front Matter....Pages 1-1
Prehypertension: Definitions, Clinical Significance and Therapeutic Approaches—To Treat or not to Treat?....Pages 3-12
Clinical Significance and Treatment Requirements in White Coat and Masked Hypertension....Pages 13-24
Resistant Hypertension: Epidemiological and Evolving Therapeutic Concepts....Pages 25-32
Primary Aldosteronism: Rare or Common Condition in Hypertensive Patients and Normotensive Individuals?....Pages 33-43
Hypertension in the Very Old: Special Features, Therapeutic Approaches, and Problems....Pages 45-56
Front Matter....Pages 57-57
Ambulatory Blood Pressure in Clinical Practice: Clinical Relevance of Circadian Rhythm and Nocturnal Dip....Pages 59-69
Morning Surge in Blood Pressure in Hypertension: Clinical Relevance, Prognostic Significance, and Therapeutic Approach....Pages 71-89
Short-Term and Long-Term Blood Pressure Variability....Pages 91-102
Home Blood Pressure Monitoring in Hypertension....Pages 103-120
Obstructive Sleep Apnea....Pages 121-131
Hypertension, Obesity, and Metabolic Syndrome....Pages 133-146
Salt, Hypertension, and Cardiovascular Disease....Pages 147-156
The Optic Fundus and Retinal Circulation: New Technology for an Old Examination....Pages 157-168
Front Matter....Pages 169-169
Arterial Stiffness as an Early Marker of Organ Damage....Pages 171-179
Central Aortic Pressure: The Next Frontier in Blood Pressure Measurement?....Pages 181-197
Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage....Pages 199-211
The Microcirculation and Hypertension....Pages 213-224
Smoking, Nicotine and Blood Pressure....Pages 225-235
Biomarkers in Hypertension....Pages 237-246
Front Matter....Pages 247-247
Antihypertensive Therapy Benefits: Pleiotropic Versus Blood Pressure-Dependent Mechanisms....Pages 249-266
Front Matter....Pages 247-247
Blood Pressure Targets with Antihypertensive Treatment....Pages 267-277
The Role of the Polypill in Hypertension....Pages 279-294
J-Curve Phenomenon: Does It Exist?....Pages 295-308
Residual Risk in Treated Hypertension....Pages 309-321
Poor BP Control in the Hypertensive Population: Which Factors are Involved?....Pages 323-330
Ramadan Fasting in Health and Disease....Pages 331-346
Postmenopausal Hormone Therapy and Blood Pressure....Pages 347-372
Treating Pain and Inflammation in Hypertension....Pages 373-387
Sexual Function in Untreated and Treated Hypertension....Pages 389-398
Cognitive Function and Dementia in Hypertension: Epidemiologic and Therapeutic Aspects....Pages 399-412
Can Hypertension Be Prevented?....Pages 413-425
Atrial Fibrillation. Modern Epidemiologic and Therapeutic Aspects....Pages 427-438
Genetics and Hypertension: Which Information for Clinical Practice....Pages 439-452
Dual Blockade of the Renin–Angiotensin–Aldosterone System: Benefits Versus Adverse Outcomes....Pages 453-465
The Long-Term Effects of RAAS Blockade on Renal Function....Pages 467-477
Back Matter....Pages 479-483